Protagenic Therapeutics, Inc.\new Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Protagenic Therapeutics, Inc.\new quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Protagenic Therapeutics, Inc.\new Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 4.8M shares, a 10.9% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 4.8M +474K +10.9% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 4.47M +136K +3.15% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 4.44M +104K +2.41% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 4.44M +114K +2.63% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 4.33M -13M -74.9% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 4.33M -13M -74.9% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 4.33M -12.9M -74.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 4.32M +18.9K +0.44% Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 17.3M +329K +1.94% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 17.3M +1.02M +6.28% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 17.3M +6.64M +62.6% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 4.3M -6.06M -58.5% Dec 31, 2021 10-K 2023-03-31
Q3 2021 17M +6.6M +63.7% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 16.3M +6M +58.5% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 10.6M +349K +3.4% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 10.4M +99.1K +0.97% Dec 31, 2020 10-K 2022-04-07
Q3 2020 10.4M +99.1K +0.97% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 10.3M 0 0% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 10.3M 0 0% Mar 31, 2020 10-Q 2020-06-18
Q4 2019 10.3M 0 0% Dec 31, 2019 10-K 2021-03-25
Q3 2019 10.3M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 10.3M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 10.3M 0 0% Mar 31, 2019 10-Q/A 2019-05-16
Q4 2018 10.3M 0 0% Dec 31, 2018 10-K 2020-04-29
Q3 2018 10.3M 0 0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 10.3M 0 0% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 10.3M +4.34K +0.04% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 10.3M +4.34K +0.04% Dec 31, 2017 10-K 2019-03-29
Q3 2017 10.3M +1.95M +23.5% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 10.3M +10.2M +11821% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 10.3M -390M -97.4% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 10.3M +3.64M +55.1% Dec 31, 2016 10-K 2018-04-02
Q3 2016 8.31M -392M -97.9% Sep 30, 2016 10-Q 2016-11-17
Q2 2016 86.1K -400M -100% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 400M 0 0% Mar 31, 2016 10-Q 2016-07-25
Q4 2015 6.61M -500 -0.01% Dec 31, 2015 10-K/A 2017-05-08
Q3 2015 400M 0 0% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 400M 0 0% Jun 30, 2015 10-Q 2016-03-11
Q1 2015 400M Mar 31, 2015 10-Q 2015-05-11
Q4 2014 6.61M Dec 31, 2014 8-K/A 2016-07-12
Q3 2014 400M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 400M Jun 30, 2014 10-K 2015-09-25
Q3 2011 6.34M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 6.33M Jun 30, 2011 10-Q/A 2011-09-07
Q4 2010 6.28M Dec 31, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.